KC
TCBP

Kepos Capital’s TC BioPharm (Holdings) plc American Depositary Shares TCBP Stock Holding History

Kepos Capital’s Portfolio TCBP Stock Details TCBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1
Closed -$264K – 597
2022
Q1 		$264K Buy
+1
New +$203K 0.02% 287

Other funds holding TCBP

Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
KC
KCL Capital New York $714M AUM 77.46% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Kepos Capital's TCBP Position: Q2 2022 in Review

Kepos Capital sold out of TC BioPharm (Holdings) plc American Depositary Shares (TCBP) in Q2 2022, closing a stake of 1 share — an estimated $264K sold.

Kepos Capital first reported a position in TCBP in Q1 2022 and held it in 1 quarter. The position peaked at $264K in Q1 2022. 3 funds tracked by Wall St. Rank hold TCBP as of Q2 2022.

  • Kepos Capital reported no remaining TC BioPharm (Holdings) plc American Depositary Shares position as of Q2 2022 after selling out during the quarter.
  • Kepos Capital sold 1 TC BioPharm (Holdings) plc American Depositary Shares share in Q2 2022, an estimated $264K.
  • Kepos Capital first reported a position in TC BioPharm (Holdings) plc American Depositary Shares in Q1 2022 and held it in 1 quarter.
  • Kepos Capital's TC BioPharm (Holdings) plc American Depositary Shares position peaked at $264K in Q1 2022.
  • 3 funds tracked by Wall St. Rank held TC BioPharm (Holdings) plc American Depositary Shares as of Q2 2022.

Based on Kepos Capital's 13F filing for Q2 2022, filed 12 Aug 2022.